Precision radiation meets new drugs in fight against brain metastases from melanoma
NCT ID NCT07691255
First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time
Summary
This study looks at how a highly targeted form of radiation called stereotactic radiosurgery (CyberKnife) works alongside newer treatments like immunotherapy and targeted therapy for people with melanoma that has spread to the brain. Researchers will observe 50 patients over time to see how long the treated brain tumors stay under control and how the timing of treatments affects outcomes. The goal is to help doctors design better treatment plans for this challenging condition.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- stereotactic radiosurgery (CyberKnife)
- What this could lead to
- If successful, this could help doctors choose the best timing and combination of radiation and newer drugs to better control melanoma that has spread to the brain.
- What could go wrong
- This is an observational study with only 50 patients, so results may not apply to everyone. It does not test a new treatment directly, and outcomes depend on many factors.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA (SKIN CANCER) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
European Institute of Oncology, Milan
Milan, Mi, 20141, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a Two-Drug combo reawaken the immune system against resistant cancers?
- Blood test may let cancer patients take safe breaks from immunotherapy
- Could a chicory root fiber supercharge immunotherapy against skin cancer?
- Can diet boost immunotherapy? study tests High-Fiber and fasting in melanoma
- Scientists harness Patients' own immune cells to attack Treatment-Resistant melanoma
- Can a simple paper tool help melanoma patients make tough biopsy decisions?